Search Results for First Biosimilar Filing in US

Showing 1 – 1

Sandoz First Company to File for Biosimilar Approval in US Under New Pathway By Alexander Gaffney, RAC - Published 24 July 2014

Biopharmaceutical company Sandoz, a Novartis subsidiary, has announced that it has filed the first-ever biosimilar application in the US with the Food and Drug Administration (FDA) using its 351(k) pathway.

Categories: News, US, CDER, Biologics and biotechnology, Submission and registration

Tags: Biosimilar, Biosimilarity, Follow-on Biologic, Sandoz, 351(k), First Biosimilar Filing in US